Previous Close | 331.30 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 26,086,278 |
Market Cap | 31.004B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 30.86 |
EPS (TTM) | 0.11 |
Earnings Date | Feb 29, 2024 |
Forward Dividend & Yield | 0.06 (1.81%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | 363.53 |
The consumer healthcare group is aiming to close the site on a phased basis over the next two years.
Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reuters on Tuesday. "Following a strategic review of our global manufacturing capabilities, we have determined that our Maidenhead site is no longer a viable option for the manufacture of our products," the spokesperson said. The making of toothpastes will be transferred to Haleon's hub in Slovakia, while mouthwash production will be moved to a third party contract manufacturer, details of which have yet to be announced.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...